Literature DB >> 16438954

Different glibenclamide-sensitivity of ATP-sensitive K+ currents using different patch-clamp recording methods.

Noriyoshi Teramoto1, Toshihisa Tomoda, Takakazu Yunoki, Yushi Ito.   

Abstract

Electorophysiological and pharmacological properties of the levcromakalim-induced inward ATP-sensitive K+ currents (K(ATP) currents) in pig proximal urethra were investigated by use of two different whole-cell patch-clamp techniques, namely conventional whole-cell and nystatin-perforated patch recordings. In conventional whole-cell configuration, the levcromakalim (100 microM)-induced K(ATP) current decayed by about 30% in 8 min at a holding potential of -50 mV. In contrast, with the nystatin-perforated patch, 96% of the levcromakalim-induced K(ATP) current still remained even after 8 min application of levcromakalim. The peak amplitude of the levcromakalim-induced inward K(ATP) currents in nystatin-perforated patch was approximately half of those observed in conventional whole-cell configuration. When cytosolic extract of pig urethra was included in the pipette solution, approximately 90% of the levcromakalim (100 microM)-induced K(ATP) current remained at 8 min, even after the establishment of conventional whole-cell configuration. In conventional whole-cell configuration, glibenclamide suppressed the levcromakalim-induced K(ATP) currents in a concentration-dependent manner (Ki=175 nM). Inclusion of 1 mM uridine 5'-diphosphate (UDP) in the pipette solution shifted the glibenclamide-sensitivity (Ki=640 nM) to the right in comparison with that in the absence of UDP (i.e., control). In contrast, using nystatin-perforated patch, glibenclamide inhibited the levcromakalim-induced K(ATP) currents with two affinity sites (high-affinity site, Ki1=10 nM; low-affinity site, Ki2=9 microM). The concentration response curves regarding the inhibitory effects of K(ATP) channel pore blockers (Ba2+ and flecainide) on the levcromakalim-induced K(ATP) currents in conventional whole-cell recording nearly overlapped with those in nystatin-perforated patch recording. These results indicate that the glibenclamide-sensitivity of pig urethral K(ATP) channels in nystatin-perforated patch recording was significantly different from that in a conventional whole-cell configuration, and that the glibenclamide-sensitivity may be modified by some cytosolic factor(s).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16438954     DOI: 10.1016/j.ejphar.2005.12.011

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Ion channels in volume regulation of clonal kidney cells.

Authors:  M B da Silva; V M A Costa; V R A Pereira; G J B de Albertim; E B B de Melo; D P Bezerra; R P da Silva; C G Rodrigues; C M M Carneiro; L N Yuldasheva; O V Krasilnikov
Journal:  Cell Prolif       Date:  2010-12       Impact factor: 6.831

2.  Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.

Authors:  Joy H Tan; Amr Al Abed; James A Brock
Journal:  J Physiol       Date:  2007-03-22       Impact factor: 5.182

3.  Vasodilation induced by oxygen/glucose deprivation is attenuated in cerebral arteries of SUR2 null mice.

Authors:  Adebowale Adebiyi; Elizabeth M McNally; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-22       Impact factor: 4.733

Review 4.  Hormone and glucose signalling in POMC and AgRP neurons.

Authors:  Bengt F Belgardt; Tomoo Okamura; Jens C Brüning
Journal:  J Physiol       Date:  2009-09-21       Impact factor: 5.182

5.  Comparative studies of ZD0947, a novel ATP-sensitive K(+) channel opener, on guinea pig detrusor and aortic smooth muscles.

Authors:  Takakazu Yunoki; Hai-Lei Zhu; Kazuomi Iwasa; Toshihisa Tomoda; Manami Aishima; Atsushi Shibata; Seiji Naito; Noriyoshi Teramoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-11       Impact factor: 3.000

6.  Glibenclamide inhibits BK polyomavirus infection in kidney cells through CFTR blockade.

Authors:  Margarita-Maria Panou; Michelle Antoni; Ethan L Morgan; Eleni-Anna Loundras; Christopher W Wasson; Matthew Welberry-Smith; Jamel Mankouri; Andrew Macdonald
Journal:  Antiviral Res       Date:  2020-03-27       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.